C-Suite Awards: Aaron Black, Inova Translational Medicine Institute, Washington Business Journal

On the surface, the goals of personalized medicine, widely considered the future of medicine, are quite clear. Put patients into groups based on their genomic makeup, give doctors an edge in identifying potential threats, and shift from reactive to preventive treatment.  But collecting and analyzing the data that drives this industry is inherently complex, and Aaron…

Read More

Personalized Healthcare: The Key to Health at Every Age

David W. Gehring, MD, is board certified in internal medicine. At Inova, we take a personalized, patient-centered approach to primary healthcare. When we treat patients, we consider their medical needs, of course. But we also consider the behaviors that drive those health needs. One key to providing personalized healthcare is considering how a patient’s medical…

Read More

The Future of Personalized Health at Inova

John Deeken, MD, is board certified in medical oncology. He specializes in treating patients with head and neck cancer. He is especially interested in using genomics to personalize cancer treatments and in developing targeted therapies. Dr. Deeken serves as associate director for Clinical Research for the Inova Dwight and Martha Schar Cancer Institute. In addition,…

Read More

Pharmacogenomics: Personalized Medicine in Action

Dr. Cannon

Timothy L. Cannon, MD, is board certified in medical oncology, hematology and internal medicine. His specialty is managing gastrointestinal cancers. Dr. Cannon emphasizes personalized care for his patients and is interested in pharmacogenomics as well as using technology to improve patients’ access to care. Read Dr. Cannon’s profile. Many patients that are receiving chemotherapy ask…

Read More

Inova and Personalis Announce Partnership to Advance Genomic Medicine

inova logo

Falls Church, VA and Menlo Park, CA – March 27, 2014 – Inova Translational Medicine Institute and Personalis, Inc. today announced a partnership to advance genomic medicine for Inova’s patient population. Personalis will collaborate with Inova on whole genome analysis and interpretation for undiagnosed syndromes in an effort to provide patients and their families an…

Read More

Ben Solomon, MD, Geneticist joins the Inova Translational Medicine Institute

FALLS CHURCH, VA (September 30, 2013) – Ben Solomon, MD, an accomplished scientist and medical geneticist has joined the the Inova Translational Medicine Institute (ITMI). Dr. Solomon will lead a new division of Medical Genomics being formed within the ITMI. The division includes a team of genetic counselors providing direct patient care. The new division…

Read More